Position
Chief Development Officer
Company
Quotient Therapeutics
CambridgeBiotechnologyHealth CareresearchDescription
Quotient Therapeutics has appointed Andrew Bayliffe, PhD, as its chief development officer. This follows several other executive appointments within the industry, highlighting a trend in leadership enhancement.
Quick answer
Quotient Therapeutics Hires Andrew Bayliffe as Chief Development Officer (October 2, 2025). Quotient Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Development Officer at Quotient Therapeutics?
- Quotient Therapeutics named Andrew Bayliffe Chief Development Officer, announced October 2, 2025.
- What did Quotient Therapeutics announce on October 2, 2025?
- Quotient Therapeutics has appointed Andrew Bayliffe, PhD, as its chief development officer. This follows several other executive appointments within the industry, highlighting a trend in leadership enhancement.
- What does Quotient Therapeutics do?
- Quotient Therapeutics is focused on advancing innovative therapies for patients.
- Where is Quotient Therapeutics based?
- Quotient Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Climb Bio, Inc. (October 1, 2025), Symeres (October 1, 2025), Tessellate Bio (October 1, 2025) and Inventiva (October 1, 2025) also announced leadership changes within 45 days of Quotient Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in research and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Climb Bio Appoints Susan Altschuller as Chief Financial Officer (October 1, 2025)
- Symeres Appoints Gabriella Gentile as Chief Operating Officer (October 1, 2025)
- Tessellate Bio Appoints Dr. Katie Chapman as Chief Scientific Officer (October 1, 2025)
- Inventiva Appoints Andrew Obenshain as Chief Executive Officer (October 1, 2025)
- KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer (October 6, 2025)
- FOXO Technologies Appoints Sylwia Nowak Hauman as Chief Financial Officer (September 26, 2025)
Who to call at Quotient Therapeutics, and when
A new leader at Quotient Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Quotient Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quotient Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quotient Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quotient Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Quotient Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.